Zobrazeno 1 - 10
of 89
pro vyhledávání: '"Hao‐Xiang Wu"'
Publikováno v:
Cancer Communications, Vol 44, Iss 1, Pp 3-22 (2024)
Abstract In recent years, remarkable breakthroughs have been reported on antibody‐drug conjugates (ADCs), with 15 ADCs successfully entering the market over the past decade. This substantial development has positioned ADCs as one of the fastest‐g
Externí odkaz:
https://doaj.org/article/8dccdbbcec754aab923da06739da0833
Autor:
Bin Zhang, Chun‐Mei Wang, Hao‐Xiang Wu, Feng Wang, Yang‐Yang Chai, Ye Hu, Bing‐Jing Wang, Zhou Yu, Rong‐Hua Xia, Rui‐Hua Xu, Xue‐Tao Cao
Publikováno v:
Cancer Communications, Vol 43, Iss 10, Pp 1097-1116 (2023)
Abstract Background The efficacy of anti‐programmed cell death protein 1 (PD‐1) immunotherapy in various cancers, including gastric cancer (GC), needs to be potentiated by more effective targeting to enhance therapeutic efficacy or identifying ac
Externí odkaz:
https://doaj.org/article/d5de8b3fbafb4c499c8dd72f28467d03
Autor:
Zhen Zhang, Zi-Xian Wang, Yan-Xing Chen, Hao-Xiang Wu, Ling Yin, Qi Zhao, Hui-Yan Luo, Zhao-Lei Zeng, Miao-Zhen Qiu, Rui-Hua Xu
Publikováno v:
Genome Medicine, Vol 14, Iss 1, Pp 1-18 (2022)
Abstract Background Although immune checkpoint inhibitor (ICI) is regarded as a breakthrough in cancer therapy, only a limited fraction of patients benefit from it. Cancer stemness can be the potential culprit in ICI resistance, but direct clinical e
Externí odkaz:
https://doaj.org/article/5f40daf4e5c248b8b7ed7187b011a379
Publikováno v:
Cancer Communications, Vol 41, Iss 9, Pp 803-829 (2021)
Abstract Cancer greatly affects the quality of life of humans worldwide and the number of patients suffering from it is continuously increasing. Over the last century, numerous treatments have been developed to improve the survival of cancer patients
Externí odkaz:
https://doaj.org/article/ec3462aed577480bb5ce01b328857f36
Autor:
Li-hong Gu, Zi-cheng Lv, Hao-xiang Wu, Yu-Chen Hou, Run-lin Gao, Zhi-feng Xi, Hua Fang, Hao Feng, Li-xin Jiang, Qiang Xia
Publikováno v:
Frontiers in Pediatrics, Vol 10 (2022)
BackgroundThe 20-year survival rate in pediatric patients after liver transplantation (LT) was no more than 70%. Hepatic fibrosis is one of the principal factors affecting the long-term prognosis. Imaging evaluation was the first-line examination for
Externí odkaz:
https://doaj.org/article/79a2b25ce1be4c6f853c33454ea53388
Autor:
Lei Xia, Zi-yun Qiao, Zi-jie Zhang, Zi-cheng Lv, Huan Tong, Ying Tong, Hao-xiang Wu, Xiao-song Chen, Han-yong Sun, Jian-jun Zhang, Wolfgang Ervin Thasler, Hao Feng, Qiang Xia
Publikováno v:
EClinicalMedicine, Vol 49, Iss , Pp 101476- (2022)
Summary: Background: The forecast accuracy of the European Association for the Study of the Liver-Chronic Liver Failure (EASL-CLIF) and Asian Pacific Association for the Study of the Liver (APASL) acute-on-chronic liver failure (ACLF) criteria in ass
Externí odkaz:
https://doaj.org/article/a7a072802e14424ba7058bb4624417c9
Autor:
Gong Chen, Junjie Peng, Qian Xiao, Hao-Xiang Wu, Xiaojun Wu, Fulong Wang, Liren Li, Peirong Ding, Qi Zhao, Yaqi Li, Da Wang, Yang Shao, Hua Bao, Zhizhong Pan, Ke-Feng Ding, Sanjun Cai, Feng Wang, Rui-Hua Xu
Publikováno v:
Journal of Hematology & Oncology, Vol 14, Iss 1, Pp 1-11 (2021)
Abstract Background Precise methods for postoperative risk stratification to guide the administration of adjuvant chemotherapy (ACT) in localized colorectal cancer (CRC) are still lacking. Here, we conducted a prospective, observational, and multicen
Externí odkaz:
https://doaj.org/article/321a0057f9af4f26ae02732160c15cad
Autor:
Meng Zhang, Chun-Feng Liu, Xiao-Yan Chen, Li-Na Yang, Chun-Mei Zhu, Jian-Hao Teng, Hao-Xiang Wu, Fu-Li Zhang
Publikováno v:
Pharmaceutical Fronts, Vol 04, Iss 02, Pp e78-e88 (2022)
The study aimed to investigate the factors affecting the stability of imipenem and cilastatin sodium for injection (IMI/CIL) to improve the quality and stability in IMI/CIL preparation. In this study, the effects of headspace oxygen (HO), water conte
Externí odkaz:
https://doaj.org/article/38a8f10a6aa44049972138636f2572d7
Publikováno v:
BMC Medicine, Vol 19, Iss 1, Pp 1-15 (2021)
Abstract Background A critical and challenging process in immunotherapy is to identify cancer patients who could benefit from immune checkpoint inhibitors (ICIs). Exploration of predictive biomarkers could help to maximize the clinical benefits. Eph
Externí odkaz:
https://doaj.org/article/58e654d12e164a6c9670a124fda70d93
Publikováno v:
Biomarker Research, Vol 8, Iss 1, Pp 1-5 (2020)
Abstract Epigenetic factors play important roles in tumor immunology. Histone-lysine N-methyltransferase 2 (KMT2) family genes exert histone H3 methylation, but its role in immunotherapy remains unclear. Our study is the first to investigate the corr
Externí odkaz:
https://doaj.org/article/8d7947db6927441ba5d0287b4c4fde80